Calderoli H, de Manzini N, Keiling R
Service de Radiothérapie, Faculté de Médecine, CHRU de Strasbourg, France.
Int Surg. 1988 Apr-Jun;73(2):112-5.
Clinical and therapeutic results in a series of 41 patients treated for inflammatory cancer of the breast lend emphasis to the selection criteria to be included in a short (approximately two months) clinical history to complement Haagensen's criteria. Chemotherapy improved the previous very poor results obtained in this condition. Survival after surgery and radiotherapy were less than 5% at five years, and this is compared with the prognosis in the series study. However, these results are still only fair in absolute terms and there is still no currently available alternative solution to attempt to achieve a marked improvement in the course of the lesion.
对41例炎性乳腺癌患者的临床和治疗结果进行分析，强调了在简短（约两个月）临床病史中应纳入的选择标准，以补充哈根森标准。化疗改善了此前在这种情况下非常差的治疗效果。手术和放疗后的五年生存率低于5%，并与系列研究中的预后情况进行了比较。然而，从绝对意义上讲，这些结果仍然只是一般，目前仍没有其他可行的替代方案来试图显著改善病变进程。
